Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling

Fms-like tyrosine kinase (FLT3) is a frequently mutated oncogene in acute myeloid leukemia (AML). FLT3 inhibitors display promising results in a clinical setting, but patients relapse after short-term treatment due to the development of resistant disease. Therefore, a better understanding of FLT3 do...

Descripción completa

Detalles Bibliográficos
Autores principales: Moharram, Sausan A., Chougule, Rohit A., Su, Xianwei, Li, Tianfeng, Sun, Jianmin, Zhao, Hui, Rönnstrand, Lars, Kazi, Julhash U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295388/
https://www.ncbi.nlm.nih.gov/pubmed/27458164
http://dx.doi.org/10.18632/oncotarget.10760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295388/
https://www.ncbi.nlm.nih.gov/pubmed/27458164
http://dx.doi.org/10.18632/oncotarget.10760

Ejemplares similares